Gene product table
Protein | Gene Symbol | All allelic disease phenotypes - locus/disease symbols |
| Bag cochaperone | BAG5 (14q32.33)     
| * Dilated cardiomyopathy, 2F - CMD2F (10.86) |
| BCL2-associated athanogene 3 | BAG3 (10q25.2-q26.2)
| * myofibrillar myopathy with bag3 defect - (5.7, 10.71, 14.75) * Charcot-Marie-Tooth disease, axonal, related to BAG3 - (5.7, 10.71, 14.75) * Dilated cardiomyopathy related to BAG3 - CMD1HH (5.7, 10.71, 14.75) |
| Beta sarcoglycan | SGCB (4q12)
| * Muscular dystrophy, limb-girdle, type 2E - LGMD2E (1.27) |
| Beta-1,3-N-acetylgalacto-saminyltransferase 2 | B3GALNT2 (1q42.3)
| * Congenital muscular dystrophy with hypoglycosylation of dystroglycan WWWS/MEB li - MDDGA11 (2.29) |
| Beta-1,4-N-acetyl-galactosaminyl transferase 1 | B4GALNT1 (12q13.3)
| * Charcot-Marie-Tooth disease, axonal - (14.100, 15.36)* Spastic paraplegia 26 - SPG26 (14.100, 15.36) |
| Bicaudal D homolog 2 (Drosophila) | BICD2 (9q22.31)
| * Arthrogryposis and BICD2-related neuromuscular disease - (12.42, 12.43, 17.24)* Spinal muscular atrophy, lower extremity, autosomal dominant 2 - SMALED2A (12.42, 12.43, 17.24)* Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2B - SMALED2B (12.42, 12.43, 17.24) |
| Blood vessel epicardial substance | BVES (6q21)
| * Limb-Girdle, Muscular dystrophy, type 2X - LGMD2X (1.38) |
| Brain expressed, associated with Nedd42 | BEAN1 (16q21)
| * spinocerebellar ataxia-31 - SCA31 (13.28) |
